N.A. Tarasova, D.R. Khastieva, N.R. Khasanov

Kazan State Medical University, Kazan

Contact details:

Tarasova N.A. — postgraduate student of the Department of Introduction to Internal Diseases named after Prof. S.S. Zimnitskiy

Address: 49 Butlerov St., 420012 Kazan, Russian Federation, tel.: +7-987-262-03-06, e-mail: aleks37@yandex.ru

According to available data, iron deficiency (ID) is a risk factor and predictor of adverse course and outcomes of cardiovascular diseases, in particular, heart failure. A smaller pool of data is accumulated in relation to coronary heart disease and myocardial infarction (MI). There are few works on the effect of iron deficiency in the patients with heart failure after myocardial infarction, hence, this topic requires further study.

The purpose — to study the changes in the maximal volume of left atrium in patients with heart failure and ID treated with iron supplements and normal iron status within 12 months after myocardial infarction.

Material and methods. The study included 106 patients (48 women (45.2%) and 58 men (54.7%)) hospitalized in Municipal Clinical Hospital No. 7 named after M.N. Sadykov with myocardial infarction in 2022–2023. The patients were divided into a group with iron deficiency — 59 (55.6%) patients, and a group without iron deficiency — 47 (44.4%) patients. The groups were comparable in terms of basic laboratory parameters, clinical and demographic characteristics, drug therapy, and prevalence of comorbidities. Atrial fibrillation was significantly more common in patients with baseline ID (11 patients, 18.6%) compared with the group without ID (2 patients, 4.25%), (p = 0.037); CHF was significantly more common in those without ID (2 patients, 3.4%) than in the group with ID (7 patients, 14.9%), (p = 0.040); inherited cardiovascular diseases were more common in patients without ID (8 patients, 13.5%) than in the group with ID (14 patients, 29.7%), (p = 0.030); smoking patients were significantly more common in the group with ID. The patients underwent iron deficiency correction. Depending on the correction, the patients were divided into 2 groups: group 1 with compensated iron deficiency (40 patients) and group 2 with non-compensated iron deficiency (19 patients). The groups were comparable in terms of basic clinical and demographic parameters, laboratory parameters, comorbidity, and drug therapy. Previous coronary artery bypass grafting (CABG), acute cerebral circulatory failure (ACBF), and MI were more frequently observed in patients with uncompensated ID. The patients underwent echocardiographic examination in the first 24 hours after hospitalization and 3, 6, 12 months later to assess the maximal volume of left atrium.

Results. Echo-CG showed a statistically significant increase in median left atrium volume after 3, 6 and 12 months compared with the initial volume in patients in the group with non-compensated ID (49.0 ml (45.5–60) initially; after 3 months — 51.0 (50–63) ml, after 6 months — 59.0 (52.0–63.0) ml, after 12 months — 59.0 (50–70) ml (р = 0.004). In the group with and without compensated ID, the left atrium volume did not change significantly (р = 0.055 and 0.289, respectively).

Conclusions. Non-compensated iron deficiency is associated with myocardial remodeling manifested in the increase of left atrium maximal volume.

Key words: iron deficiency, myocardial infarction, maximal left atrium volume, chronic heart failure.

REFERENCES

1. Alnuwaysir R.I.S. Iron deficiency in heart failure: mechanisms and pathophysiology. J. Clin. Med, 2021, vol. 11 (1), pp. 125. DOI: 10.3390/jcm11010125
2. Wischmann P., Chennupati R., Solga I. et al. Safety and efficacy of iron supplementation after myocardial infarction in mice with moderate blood loss anemia. ESC Heart Fail, 2021, vol. 8 (6), pp. 5445–5455. DOI: 10.1002/ehf2.13639
3. Sitnikova M.Yu., Lyasnikova E.A., Yurchenko A.V. et al. Results of 3 years of work of the Russian hospital registry of chronic heart failure (RUssian hoSpital Heart Failure Registry — RUS-HFR): the relationship between management and outcomes in patients with chronic heart failure. Kardiologiya, 2018, vol. 58 (10S), pp. 9–19 (in Russ.). DOI: 10.18087/cardio.2483
4. Anker S.D., Comin Colet J., Filippatos G. et al. FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med, 2009, vol. 361 (25), pp. 2436–2448. DOI: 10.1056/NEJMoa0908355
5. Okonko D.O., Grzeslo A., Witkowski T. et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J. Am. Coll. Cardiol, 2008, vol. 51 (2), pp. 103–112. DOI: 10.1016/j.jacc.2007.09.036
6. Ponikowski P., van Veldhuisen D.J., Comin-Colet J. et al. CONFIRM-HF Investigators Beneficial effects of long-term intravenous iron therapy with ferric car-boxymaltose in patients with symptomatic heart failure and iron deficiency. Eur. Heart J, 2015, vol. 36 (11), pp. 657–668. DOI: 10.1093/eurheartj/ehu385
7. van Veldhuisen D.J., Ponikowski P., van der Meer P. et al. EFFECT-HF Investigators. Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation, 2017, vol. 136 (15), pp. 1374–1383. DOI: 10.1161/CIRCULATIONAHA.117.027497
8. Tullio M., Qian M., Thompson J. et al. Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment. ESC Heart Fail, 2018, vol. 5, pp. 800–808. DOI: 10.1002/ehf2.12331
9. Ahmeti A., Bytyçi F.S., Bielecka-Dabrowa A. et al. Prognostic value of left atrial volume index in acute coronary syndrome: A systematic review and meta-analysis. Clin. Physiol. Funct. Imaging, 2021, vol. 41 (2), rr. 128–135. DOI: 10.1111/cpf.12689
10. Kizer J.R., Bella J.N., Palmieri V. et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am. Heart J, 2006, vol. 151 (2), rr. 412–418. DOI: 10.1016/j.ahj.2005.04.031
11. Moller J.E., Hillis G.S., Oh J.K. et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation, 2003, vol. 107 (17), pp. 2207–2212. DOI: 10.1161/01.CIR.0000066318.21784.43
12. Klinicheskie rekomendatsii. Khronicheskaya serdechnaya nedostatochnost’, 2024 [Clinical guidelines. Chronic heart failure, 2024], available at: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_HSN-unlocked.pdf
13. Klinicheskie rekomendatsii. Ostryy infarkt miokarda s pod»emom segmenta ST elektrokardiogrammy. 2020 [Clinical guidelines. Acute myocardial infarction with ST segment elevation of the electrocardiogram. 2020], available at: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_HSN-unlocked.pdf
14. Thygesen K., Alpert J., Jaffe A. et al. Fourth universal definition of myocardial infarction (2018). Circulation, 2018, vol. 138 (20), pp. e618–e651. DOI: 10.1161/CIR.0000000000000617
15. Shen J., Zhou Q., Liu Y. et al. Evaluation of left atrial function in patients with iron-deficiency anemia by two-dimensional speckle tracking echocardiography. Cardiovasc Ultrasound, 2016, vol. 14 (1), p. 34. DOI: 10.1186/s12947-016-0078-z
16. Dereli S., Bayramoğlu A., Özer N. et al. Evaluation of left atrial volume and function by real time three-dimensional echocardiography in anemic patients without overt heart disease before and after anemia correction. Int. J. Cardiovasc. Imaging, 2019, vol. 35 (9), pp. 1619–1626. DOI: 10.1007/s10554-019-01609-6